Long-term treatment with inotersen and potential improvement of amyloid transthyretin cardiomyopathy

被引：0
|
作者：
Dasgupta, N. R. [1 ]
Benson, M. D. [2 ]
机构：
[1] Indiana Univ Sch Med, Div Cardiol, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P560
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Long-term Treatment with Inotersen for Amyloid Transthyretin Amyloidosis Cardiomyopathy
    Dasgupta, Noel
    Benson, Merrill
    [J]. JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S59 - S59
  • [2] SAFETY OF INOTERSEN TREATMENT IN PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
    Dasgupta, Noel R.
    Falk, Rodney H.
    Drachman, Brian M.
    Maurer, Mathew S.
    Whelan, Carol J.
    Brannagan, Thomas
    Coelho, Teresa
    Cruz, Marcia Waddington
    Damy, Thibaud
    Hanna, Mazen
    Berk, John L.
    Merlini, Giampaolo
    Conceicao, Isabel
    Hughes, Steven G.
    Kwoh, Jesse
    Jung, Shiangtung W.
    Guthrie, Spencer
    Pollock, Michael
    Gertz, Morie
    Benson, Merrill D.
    Heitner, Stephen
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 909 - 909
  • [3] Inotersen therapy of transthyretin amyloid cardiomyopathy
    Dasgupta, Noel R.
    Rissing, Stacy M.
    Smith, Jessica
    Jung, Jeesun
    Benson, Merrill D.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2020, 27 (01): : 52 - 58
  • [4] Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    [J]. CIRCULATION-HEART FAILURE, 2022, 15 (01) : E008193
  • [5] Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy
    Damy, T.
    Elliott, P.
    Gundapaneni, B.
    Tai, S. See
    Sultan, M. B.
    Drachman, B. M.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2142 - 2142
  • [6] Monitoring Patisiran and Inotersen Treatment by Quantitative SPECT/CT in Hereditary Transthyretin Amyloid Cardiomyopathy
    Rettl, R.
    Calabretta, R.
    Duca, F.
    Binder, C.
    Kronberger, C.
    Dona, C.
    Nitsche, C.
    Beitzke, D.
    Loewe, C.
    Auer-Grumbach, M.
    Kastl, S.
    Bonderman, D.
    Hengstenberg, C.
    Eslam, R. Badr
    Kastner, J.
    Bergler-Klein, J.
    Hacker, M.
    Kammerlander, A.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S467 - S468
  • [7] Monitoring patisiran and inotersen treatment with quantitative SPECT/CT in hereditary transthyretin amyloid cardiomyopathy
    Rett, R.
    Calabretta, R.
    Duca, F.
    Binder, C.
    Kronberger, C.
    Dona, C.
    Beitzke, D.
    Loewe, C.
    Bonderman, D.
    Hengstenberg, C.
    Eslam, R. Badr
    Kastner, J.
    Bergler-Klein, J.
    Hacker, M.
    Kammerlander, A. A.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [8] Long-term Survival Benefit of Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
    Patel, Jignesh
    Elliott, Perry
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla
    Grogan, Martha
    [J]. JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S64 - S65
  • [9] Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy
    Barge-Caballero, G.
    Barge Caballero, E.
    Lopez-Perez, M.
    Bilbao-Quesada, R.
    Gonzalez-Babarro, E.
    Gomez-Otero, I.
    Lopez-Lopez, A.
    Gutierrez-Feijoo, M.
    Varela-Roman, A.
    Gonzalez-Juanatey, C.
    Diaz-Castro, O.
    Crespo-Leiro, M.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1806 - 1806
  • [10] Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms
    Elliott, Perry
    Gundapaneni, Balarama
    Sultan, Marla B.
    Ines, Monica
    Garcia-Pavia, Pablo
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (11) : 2060 - 2064
12345